MALAYSIA · MEDICAL DEVICES

Can multiple models go in one Malaysian application? How to group or split

A catalogue lists twenty models. Does a Malaysian registration need one application or twenty? It depends on how the models actually differ. The same brand, the same factory or the same series number is not, on its own, enough to justify combining them. The MDA allows eligible devices to be grouped into one application, but every grouping must meet three basic rules (one proprietary name, one manufacturer, one common intended purpose) as well as the specific conditions of the chosen category. (Sources: MDA/GD/0005, 2nd edition, sections 4.1–4.2; MDA/GD/0054, 2nd edition, section 4)

This article covers only how to set the scope of a first registration. Adding models to, or changing the intended use of, a registered device is assessed separately under the change rules. For the registration holder, CAB assessment and the overall process, see our Malaysia medical device registration service.

First, pick the right grouping guidance

General medical devices follow MDA/GD/0005 “General Medical Device – Grouping”, 2nd edition. Section 2 of that edition excludes in vitro diagnostic devices from its scope, and a note points to the IVD-specific MDA/GD/0054. Applying the GMD Family or Set conditions to test reagents means choosing the wrong framework at the very first step. (Source: GD/0005, 2nd edition, section 2)

The two documents use different grouping categories:

GuidanceGrouping categoriesSpecific provisions
GD/0005 (general medical devices)Single, System, Family, SetIVF devices (4.3.5), hearing aids (4.3.6)
GD/0054 (IVDs)Single, System, Family, IVD Test Kit, IVD ClusterImmunohistochemistry (IHC, 6.1), FISH probes (6.2)

A practical order of questions: can each model achieve its medical purpose on its own, or only together with other components? Then decide whether the models are variants of one product (Family), components used together (System), or several devices assembled into one pack by the manufacturer (Set). Family is not a default choice, and the number of devices in a box does not by itself make a Set.

Family: evidence for each of the six conditions

Under clause 4.3.3.1 of GD/0005, Family members must come from the same manufacturer, have the same risk classification, carry the same medical device proprietary name, share a common intended purpose, have the same design and manufacturing process, and differ only within the permissible variants. Put each of the six conditions into a model comparison table and support it with labels, specifications, process descriptions and verification data. (Source: GD/0005, 2nd edition, clause 4.3.3.1, p. 4)

Actual difference between modelsWhat to checkEffect on application scope
Pack quantity onlyWhether the device, intended use and specifications are otherwise identicalThe guidance example: condoms in packs of 3, 12 and 144 can be registered as one Single (4.3.1); no Family is needed for pack sizes.
Length, size, number of lumens, etc.Whether Annex C lists the difference, plus the other five Family conditionsA Family is possible if every condition is met; examples include IV administration sets with different tubing lengths and cardiac catheters with different numbers of lumens and lengths (4.3.3.2).
Different materialThe specific material change and its design and risk impactThe general rule is that “materials are not regarded as being on the list of permissible variations”; titanium and stainless steel instruments may not share a Family (4.3.3.4). Annex C does, however, list material variants for specific devices, such as bracket material for dental brackets, handpiece material for dental handpieces, scintillator material for X-ray detectors, and coating material for lubrication only. Outside those entries, usually split.
Different intended use or designIFU, performance, design and manufacturing differencesThe guidance example: toric and spherical contact lenses differ in purpose and design and are not one Family (4.3.3.2(f)).
Different proprietary name or manufacturerProprietary name on the label; legal manufacturer detailsFails the basic rules, so not one Family; the proprietary name must appear on each member’s label (4.3.3.4).

Annex C is a “closed and positive list” of permissible variants and should be read together with the specific clauses and examples. A difference allowed for one device type does not justify the same grouping for every device. Where the list does not support a difference, confirm with the CAB or the MDA first rather than stretching “technically similar” into “permitted”. (Source: GD/0005, 2nd edition, Annex C, pp. 14–17)

Illustrative example: sorting four infusion set models

The following is a hypothetical example to illustrate the method; it does not represent an assessment outcome for any real product. A manufacturer plans to register four infusion set models: A and B differ only in tubing length; C uses the same base design with a different main patient-contact material; D has a different clinical use.

ModelDifference from APreliminary view
A, BTubing length onlyIf risk class, proprietary name, material, process and intended use are the same, assess as one Family by reference to the guidance example on IV set tubing length.
CMain contact materialAnnex C lists no material variant for infusion sets, so under the general rule C cannot join the A/B Family; file separately or confirm with the CAB/MDA first.
DClinical useNo common intended purpose, so a shared commercial series name cannot bring it in; group it according to its own use.

After the preliminary grouping, map the models to be sold against labels and supporting evidence. The number of applications then follows from the evidence, rather than fixing on one application first and rewriting product descriptions to fit.

System and Set: how the products are actually sold matters

A System requires components from the same manufacturer that are compatible, used together for a common intended purpose, and sold under a System name or labelled for use with the System. Section 4.3.2 of GD/0005 distinguishes three situations:

  • components registered as part of a System may be supplied only for use with that System;
  • components supplied for several Systems must be registered with each of them, or registered separately where applicable;
  • accessories or components supplied separately by different manufacturers must be registered separately; accessories from a different manufacturing site that are supplied together with the device under one proprietary name may be included in the same application.

Showing components together in a catalogue is no substitute for evidence of compatibility and supply scope. (Source: GD/0005, 2nd edition, section 4.3.2, pp. 3–4)

A Set is two or more devices assembled into one package by the manufacturer under a single Set name and a common intended use, classified at the level of the highest-class device in it. Information on all devices in the Set must be submitted in one application, and any device to be supplied separately must be registered individually. Promotional or convenience packs without a Set name or common intended purpose are not registered as a Set; each device in them needs its own Single registration. (Source: GD/0005, 2nd edition, section 4.3.4, pp. 7–8) When planning, spell out what is sold as a Set and what is sold as a separate replacement part; otherwise the registration may not cover the supply arrangements your sales team intends.

IVDs: go back to the test purpose and the specific rules

Under GD/0054, reagents, instruments and calibrators do not automatically belong in one application. The table lists the limits most often overlooked: (Source: GD/0054, 2nd edition, sections 5.2–5.5, pp. 6–11)

CategoryKey conditionsLimits easily missed
SystemSame manufacturer, common purpose, compatible; may include an analyser and its reagentsAssays on one analyser may be split into several applications by risk class (the 5.2.11 example uses one Class D and one Class C application).
FamilyThe same six conditions as for GMDsUrinalysis strips with different test combinations can be one Family (Table 3 example); this does not extend to other tests.
IVD Test KitSame manufacturer, used together for a specific purpose, sold under one kit name, compatibleExcludes instruments such as analysers needed to perform the test (5.4.2); reagents from another manufacturer may be included only with full information, including that manufacturer’s authorisation (5.4.6).
IVD ClusterSame manufacturer, Class A or B, same methodology, cluster category and test principleCluster categories are a closed list in Annex E; the grouping applies to registration only and cannot be used to add models through a change notification (5.5.8).

For multiplex products, first list each configuration’s analytes, specimen type, user, result output and overall intended use, then check the applicable grouping. Professional-use and self-test versions have different users, so check whether classification and performance evidence still support a joint application. For IVD registration more broadly, see our IVD registration service.

Before submission, align everything in one model matrix

The MDA submission guide requires the application to list the devices with their identifiers (bar code, catalogue, model or part number, UDI) and a description, on the basis of the grouping criteria in MDR 2012 (GD/0005 for devices, GD/0054 for IVDs). (Source: MDA/GD/0070, 2nd edition, Annex 4 section 3, p. 27)

MediPass suggests a matrix with at least the following columns. It is a project-preparation tool and does not replace the MDA’s forms or technical documentation:

  • model/catalogue number, UDI, proprietary name, legal manufacturer and manufacturing site;
  • risk class and classification rationale, intended use and user;
  • key specifications, materials or composition, sterilisation method, packaging and supply mode (single, set, replacement part);
  • the corresponding label, IFU version and verification reports;
  • the grouping clause or Annex C/Annex E entry relied on for each difference.

We also suggest checking that several scopes match: the models in the manufacturer’s authorisation, those covered by the CAB certificate and report, the ISO 13485 certificate scope, the reference-country approval (if using the verification route), and the model list to be submitted in MeDC@St. GD/0070 requires the QMS certification scope to apply to the device and the CAB certificate and report to be submitted; checking model by model is our recommended practice, not a stated requirement of the guidance. (Source: GD/0070, 2nd edition, Annex 4 sections 5 and 7) For the verification route conditions, see Malaysia–Singapore regulatory reliance pathways.

Frequently asked questions

All our models are on one CE certificate. Can they simply be combined?
No. Each must still meet the Malaysian grouping rules. The scope of a foreign certificate is useful cross-checking material, but which models it covers and which models can go into one MDA application are separate questions.

Can two brands from the same manufacturer form one Family?
No. The basic rules and the Family conditions in GD/0005 (2nd edition) both require the same proprietary name, and a common manufacturer does not make up for different names. Group each brand under its own name.

Can we register a few models first and add the rest later?
New models are assessed under the change rules for their differences and change category; the grouping decision in the first application is not an open licence to add models. GD/0054 also states that an IVD Cluster cannot be used as the basis for adding models through a change notification. See Malaysia post-registration changes (GD/0020).

Should we combine as much as possible to save on fees?
Establish the compliant application boundary first, then compare fees and maintenance. Forcing models together leaves authorisations, labels and evidence misaligned; a sensible split can also let different product lines be submitted on their own timelines.

Can IVDs of different risk classes go into one application?
GD/0054 does not prohibit this across the board, but a Family requires the same risk class, a Cluster is limited to Class A and B, and the guidance’s System example splits assays into a Class D and a Class C application. Check the conditions of the specific category.

Official references

  1. Medical Device Authority, MDA/GD/0005 General Medical Device – Grouping, 2nd edition, section 2 (scope, excludes IVDs), sections 4.1–4.3.4 (grouping categories and conditions), Annex C (permissible variants), cover dated January 2024, published on the MDA website 30 January 2024, mda.gov.my
  2. Medical Device Authority, MDA/GD/0054 Guidance on the Product Grouping for In-Vitro Diagnostic (IVD) Medical Devices, 2nd edition, section 4, sections 5.2–5.5, Annex E, January 2021, portal.mda.gov.my (PDF)
  3. Medical Device Authority, MDA/GD/0070 Medical Device Registration Submission Guide for Conformity Assessment by way of Verification Process and Submission of Application in MeDC@St, 2nd edition, Annex 4 sections 3, 5 and 7, October 2025 (revision history 13 October 2025), portal.mda.gov.my (PDF)

Prepared from official sources verifiable as of 15 October 2025 for manufacturers’ project planning; the grouping of a specific product must be assessed against its actual use, design and the applicable guidance, and confirmed with the CAB and the MDA.

Leave a Comment

Your email address will not be published. Required fields are marked *

Chat on WhatsAppWhatsApp 咨询